Picture of Basilea Pharmaceutica AG, Allschwil logo

BSLN — Basilea Pharmaceutica AG, Allschwil News Story

0.000.00%
ch flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Brief: Basilea Announces Zevtera (Ceftobiprole) Marketing Authorization In Brazil

July 12 (Reuters) - Basilea Pharmaceutica AG  BSLN.S :
    * BASILEA ANNOUNCES ZEVTERA® (CEFTOBIPROLE) MARKETING
AUTHORIZATION IN BRAZIL

Source text for Eikon:  ID:nGNERwWWX 
Further company coverage:  BSLN.S 

 ((frankfurt.newsroom@thomsonreuters.com;))

Recent news on Basilea Pharmaceutica AG, Allschwil

See all news